Analytics

>

Latest News

Credit: Egor | stock.adobe.com. Key developments such as the application of artificial intelligence (AI), broader use of real-world evidence (RWE), decentralized clinical trials (DCTs), master protocols, risk-based quality monitoring (RBQM), and precision medicine are shaping the future of research.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success

July 7th 2025

How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.

Eric Karofsky is an award-winning CX, UX, and employee engagement industry expert who leads VectorHX, a human experience agency
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma

June 23rd 2025

© photon_photo - © photon_photo - stock.adobe.com
Less is More in Clinical Data: The Road to Simpler and Better Trials

May 20th 2025

Credit: WrightStudio | stock.adobe.com
Turning Uncertainty into Opportunity: Smarter Clinical Asset Evaluation Powered by Causal Machine Learning

February 18th 2025

The Transformative Power of Data Analytics in Clinical Trials
The Transformative Power of Data Analytics in Clinical Trials

February 10th 2025

Video Interviews

More News

Credit: JYPIX | stock.adobe.com

Decentralized Phase I Trial Highlights Promise of Remote Data Collection to Improve Clinical Research

Davy James
January 22nd 2025

Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and monitoring, which could improve patient access and enhance the efficiency of clinical research.

Insight-Driven Strategies: Elevating Patient Centricity in Clinical Trials

Insight-Driven Strategies: Elevating Patient Centricity in Clinical Trials

IQVIA
October 11th 2024

Webinar Date/Time: Wednesday, November 13th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Platform Trials: A Biostatistics Perspective

Platform Trials: A Biostatistics Perspective

IQVIA
October 3rd 2024

Webinar Date/Time: Tuesday, January 21st, 2025 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Navigating eCOA Instrument Licensing and Translation for Pharma and Biotech Professionals

Navigating eCOA Instrument Licensing and Translation for Pharma and Biotech Professionals

YPrime
October 3rd 2024

Webinar Date/Time: Wed, Oct 23, 2024 11:00 AM EDT

Clinical Trial Diversity in Action: A Site Roadmap for Sponsors and CROs

Clinical Trial Diversity in Action: A Site Roadmap for Sponsors and CROs

Avacare
September 27th 2024

Webinar Date/Time: Wed, Oct 30, 2024 11:00 AM EDT

Understanding Site and Patient Challenges: Empowering Sponsors to Drive Trial Success

Understanding Site and Patient Challenges: Empowering Sponsors to Drive Trial Success

YPrime
September 4th 2024

Webinar Date/Time: Wed, Sep 25, 2024 11:00 AM EDT

Centralized / Regional Support From Local to Global: The Power of Centralized Hubs

From Local to Global: The Power of Centralized Hubs

IQVIA
August 12th 2024

Webinar Date/Time: Tuesday, September 10th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Cell and Gene Therapy Clinical Development: Strategies From Design to Delivery

Cell and Gene Therapy Clinical Development: Strategies From Design to Delivery

IQVIA
August 2nd 2024

Webinar Date/Time: Tuesday, August 27, 2024 at 11:00 AM EDT | 8:00 AM PDT | 4:00 PM BST | 5:00 PM CEST

Patient Technology: Implement the Right Technology at the Right Time for Your Trial

Patient Technology: Implement the Right Technology at the Right Time for Your Trial

IQVIA
July 15th 2024

Webinar Date/Time: Tuesday, August 13th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Operational Oversight in Clinical Research: Integrations and Insights

Operational Oversight in Clinical Research: Integrations and Insights

IQVIA
June 5th 2024

Webinar Date/Time: Thursday, June 27th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Improve Study Outcomes Through Site-Centered eConsent Solutions

Maximize your Study’s Potential: How Expert Recommendations on Data Collection, Data Flow, Standards and AI can Transform Outcomes

IQVIA
April 5th 2024

Webinar Date/Time: Thursday, May 9th, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Using Standards Experts to Empower End-to-End Data Flow

Using Standards Experts to Empower End-to-End Data Flow

IQVIA
February 14th 2024

Webinar Date/Time: Tuesday, March 12th, 2024 at 12pm EDT | 9am PDT | 4pm GMT | 5pm CET

Image credit: AndSus | stock.adobe.com. Circuit board in shape electronic brain with gyrus, symbol ai hanging over hand. Symbol of computer neural networks or artificial intelligence in neon cyberspace with glowing title on palm scientist

Bringing AI Out of the Shadows and into the Physical World of Drug Development

Peter Madrid
February 9th 2024

While many groups rely on manual chemistry processes, innovative platforms have emerged that allow these protocols to be executed on custom automation systems.

The Past, Present and Future of Mobile Visits in Decentralized Clinical Trials

The Past, Present and Future of Mobile Visits in Decentralized Clinical Trials

PCM Trials
February 5th 2024

Webinar Date/Time: Wed, Mar 27, 2024 11:00 AM EDT

The Digital Transformation of RBQM

The Digital Transformation of RBQM

IQVIA
January 1st 2024

Webinar Date/Time: Wednesday, January 31st, 2024 at 9am EST | 6am PST | 2pm GMT | 3pm CET

‘Hypothesis-Free’: Getting Proactive About Signal Detection

‘Hypothesis-Free’: Getting Proactive About Signal Detection

Mike Hollan
December 5th 2023

Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.

Artificial Intelligence Has the Potential to Transform Clinical Trials, Study Says

Artificial Intelligence Has the Potential to Transform Clinical Trials, Study Says

Don Tracy, Associate Editor
November 15th 2023

Findings suggests implementation could save time and money, but needs to be evaluated carefully.

How to Achieve Comprehensive Oversight of Your Entire Portfolio of Clinical Trials

How to Achieve Comprehensive Oversight of Your Entire Portfolio of Clinical Trials

IQVIA
November 10th 2023

Webinar Date/Time: Tuesday, December 12th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Validation Considerations for AI-Enabled SaaS

Validation Considerations for AI-Enabled SaaS

IQVIA
October 27th 2023

Webinar Date/Time: Thursday, November 9th, 2023 Option 1: 9am EST | 6am PST | 2pm GMT | 3pm CET

How Statistical Modeling and Simulation is Supporting Drug Development

How Statistical Modeling and Simulation is Supporting Drug Development

IQVIA
October 23rd 2023

Webinar Date/Time: Wednesday, November 15th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Reinventing Prospective Study Data Acquisition & Delivery

Reinventing Prospective Study Data Acquisition & Delivery

Flatiron
October 6th 2023

Webinar Date/Time: Tue, Oct 17, 2023 11:00 AM EDT

Voice of Pharma Study: Sponsor Views on Clinical Data Analytics and AI

Voice of Pharma Study: Sponsor Views on Clinical Data Analytics and AI

IQVIA
August 30th 2023

Webinar Date/Time: Tuesday, October 3rd, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

The Future of SDTM Transformation: AI and HITL

The Future of SDTM Transformation: AI and HITL

Aman Thukral;Sanjay Bhardwaj
July 11th 2023

Using an AI + Human in the Loop (HITL) approach can be utilized for Study Data Tabulation Model (SDTM) transformation, potentially alleviating current challenges

Oversight Method Identifies Critical Errors Missed by Traditional Monitoring Approaches

Oversight Method Identifies Critical Errors Missed by Traditional Monitoring Approaches

Kevin T. Fielman, PhD;Karina M. Soto-Ruiz, MD;Penelope K. Manasco, MD
June 22nd 2023

Study Health Check provides early identification of issues related to protocol deviations and determines objective measures of site-specific versus study-wide performance.

A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by Grade

A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by Grade

Gen Li, PhD, MBA;Jonathan Peachey;Paul Chew, MD;Peter M. O’Neill
May 26th 2023

Using existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.

AI and ML are Transforming Clinical Research Practice

AI and ML are Transforming Clinical Research Practice

Betsy Wagner
May 17th 2023

Three case studies showcase ability of AI and ML in overcoming challenges with data, resourcing, and more.

Site Logo

How Reverse-Engineering Clinical Trials to Leverage the AI-based-Digital Twin Solution Solves for Many Current Issues

John Varaklis
April 5th 2023

These devices can help researchers identify data points that are not immediately available to researchers.

How to Use Hidden Data Flow to Accelerate Your Trials in an Inflation Reduction Act Environment

How Generative AI and Chat GPT Together with Intelligent Document Review Can Help Pharma Accelerate Filings

IQVIA
March 20th 2023

Webinar Date/Time: Session 1: Tuesday, April 18th, 2023 at 8am EDT | 1pm BST | 2pm CEST Session 2: Tuesday, April 18th, 2023 at 2pm EDT | 11am PDT | 7pm BST

How NLP Surfaces Adverse Events and Safety Insights to Improve Drug Safety Processes

How NLP Surfaces Adverse Events and Safety Insights to Improve Drug Safety Processes

Jane Reed, director, life sciences NLP, IQVIA
March 17th 2023

Use cases show benefits of unlocking data to improve signal and adverse event detection.

How Robust Data Technology is Transforming the Design and Execution of Viable Clinical Trials

How Robust Data Technology is Transforming the Design and Execution of Viable Clinical Trials

March 7th 2023

Mike Gallup, CEO, Norstella, Ashley Schwalje, Senior Director, Clinical Solutions Consulting, Citeline

12>
© 2025 MJH Life Sciences

All rights reserved.